Behavioral Addictions _ _______________________________________________________________________
SWUS15BA — 15 CE HOURS
R elease D ate : 05/01/24
E xpiration D ate : 04/30/27
Behavioral Addictions
Audience This course is designed for mental health practitioners who may intervene in diagnosing and treating behavioral addictions in their patients. Course Objective The purpose of this course is to provide clinicians with the knowledge and skills to appropriately identify, diagnose, and treat behavioral addictions. Learning Objectives Upon completion of this course, you should be able to: 1. Outline the evolution of and concepts forming the basis of behavioral addictions. 2. Compare and contrast explanatory models of addic- tion and their applicability to behavioral addictions. 3. Describe the factors underlying child and adolescent vulnerability to behavioral addictions. 4. Discuss psychological and pharmacologic treatments that are generally appropriate for behavioral addic- tion. 5. Analyze the epidemiology, comorbidity, and risk fac- tors of gambling disorder. 6. Evaluate the diagnosis and treatment of gambling disorder. 7. Review the pathophysiology, diagnosis, and treatment of addictive sexual behavior. 8. Describe Internet gaming disorder and how it is diag- nosed and treated. 9. Explain how binge eating disorder is identified and appropriately treated. 10. Outline the epidemiology, risk factors, and clinical characteristics of compulsive buying disorder. 11. Analyze factors related to the diagnosis and treatment of compulsive buying disorder. 12. Discuss the epidemiology, comorbidities, and patho- physiology of trichotillomania. 13. List approaches to the treatment of trichotillomania. 14. Identify patients with kleptomania and create an effec- tive treatment plan for these patients. 15. Describe behavioral addictions induced by dopamine agonists and other medications and disorders.
Faculty Mark Rose, BS, MA, LP , is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contrib- uted to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer-reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/ toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations. Faculty Disclosure Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Division Planners Alice Yick Flanagan, PhD, MSW Margaret Donohue, PhD Senior Director of Development and Academic Affairs Sarah Campbell Division Planners/Director Disclosure The division planners and director have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Accreditations & Approvals As a Jointly Accredited Organization, NetCE is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit.
Mention of commercial products does not indicate endorsement.
24
EliteLearning.com/Social-Work
Powered by FlippingBook